BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 12610779)

  • 1. Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk.
    Hwang SJ; Lozano G; Amos CI; Strong LC
    Am J Hum Genet; 2003 Apr; 72(4):975-83. PubMed ID: 12610779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk.
    Hwang SJ; Cheng LS; Lozano G; Amos CI; Gu X; Strong LC
    Hum Genet; 2003 Aug; 113(3):238-43. PubMed ID: 12802680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome.
    Wu CC; Shete S; Amos CI; Strong LC
    Cancer Res; 2006 Aug; 66(16):8287-92. PubMed ID: 16912210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations.
    Fang S; Krahe R; Lozano G; Han Y; Chen W; Post SM; Zhang B; Wilson CD; Bachinski LL; Strong LC; Amos CI
    PLoS One; 2010 May; 5(5):e10813. PubMed ID: 20520810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma.
    Toguchida J; Yamaguchi T; Dayton SH; Beauchamp RL; Herrera GE; Ishizaki K; Yamamuro T; Meyers PA; Little JB; Sasaki MS
    N Engl J Med; 1992 May; 326(20):1301-8. PubMed ID: 1565143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohort.
    Mitchell G; Ballinger ML; Wong S; Hewitt C; James P; Young MA; Cipponi A; Pang T; Goode DL; Dobrovic A; Thomas DM;
    PLoS One; 2013; 8(7):e69026. PubMed ID: 23894400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation or birth cohort effect on cancer risk in Li-Fraumeni syndrome.
    Brown BW; Costello TJ; Hwang SJ; Strong LC
    Hum Genet; 2005 Dec; 118(3-4):489-98. PubMed ID: 16284780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic transmission of susceptibility to cancer in families of children with soft tissue sarcomas.
    Moutou C; Le Bihan C; Chompret A; Poisson N; Brugières L; Bressac B; Feunteun J; Lemerle J; Bonaïti-Pellié C
    Cancer; 1996 Oct; 78(7):1483-91. PubMed ID: 8839555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database.
    Ognjanovic S; Olivier M; Bergemann TL; Hainaut P
    Cancer; 2012 Mar; 118(5):1387-96. PubMed ID: 21837677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
    Mai PL; Best AF; Peters JA; DeCastro RM; Khincha PP; Loud JT; Bremer RC; Rosenberg PS; Savage SA
    Cancer; 2016 Dec; 122(23):3673-3681. PubMed ID: 27496084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.
    Lee DS; Yoon SY; Looi LM; Kang P; Kang IN; Sivanandan K; Ariffin H; Thong MK; Chin KF; Mohd Taib NA; Yip CH; Teo SH
    Breast Cancer Res; 2012 Apr; 14(2):R66. PubMed ID: 22507745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone and Soft-Tissue Sarcoma Risk in Long-Term Survivors of Hereditary Retinoblastoma Treated With Radiation.
    Kleinerman RA; Schonfeld SJ; Sigel BS; Wong-Siegel JR; Gilbert ES; Abramson DH; Seddon JM; Tucker MA; Morton LM
    J Clin Oncol; 2019 Dec; 37(35):3436-3445. PubMed ID: 31622129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of germline and tumor mutations of p53 gene in familial occurrence of soft tissue sarcomas.
    Kudawara I; Matsumine A; Ohzono K
    J Surg Oncol; 2007 Mar; 95(4):347-50. PubMed ID: 17192950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study.
    de Andrade KC; Khincha PP; Hatton JN; Frone MN; Wegman-Ostrosky T; Mai PL; Best AF; Savage SA
    Lancet Oncol; 2021 Dec; 22(12):1787-1798. PubMed ID: 34780712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of p53 and PTEN in soft tissue sarcoma.
    Yin L; Liu CX; Nong WX; Chen YZ; Qi Y; Li HA; Hu WH; Sun K; Li F
    Mol Med Rep; 2012 Feb; 5(2):457-61. PubMed ID: 22052239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
    Gonzalez KD; Noltner KA; Buzin CH; Gu D; Wen-Fong CY; Nguyen VQ; Han JH; Lowstuter K; Longmate J; Sommer SS; Weitzel JN
    J Clin Oncol; 2009 Mar; 27(8):1250-6. PubMed ID: 19204208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe.
    Bright CJ; Hawkins MM; Winter DL; Alessi D; Allodji RS; Bagnasco F; Bárdi E; Bautz A; Byrne J; Feijen EAM; Fidler MM; Garwicz S; Grabow D; Gudmundsdottir T; Guha J; Haddy N; Jankovic M; Kaatsch P; Kaiser M; Kuehni CE; Linge H; Øfstaas H; Ronckers CM; Skinner R; Teepen JC; Terenziani M; Vu-Bezin G; Wesenberg F; Wiebe T; Sacerdote C; Jakab Z; Haupt R; Lähteenmäki P; Zaletel LZ; Kuonen R; Winther JF; de Vathaire F; Kremer LC; Hjorth L; Reulen RC;
    J Natl Cancer Inst; 2018 Jun; 110(6):649-660. PubMed ID: 29165710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 gene gets altered by various mechanisms: studies in childhood sarcomas and retinoblastoma.
    Ghule P; Kadam PA; Jambhekar N; Bamne M; Pai S; Nair C; Banavali S; Puri A; Agarwal M
    Med Sci Monit; 2006 Dec; 12(12):BR385-396. PubMed ID: 17136003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage.
    Zerdoumi Y; Lanos R; Raad S; Flaman JM; Bougeard G; Frebourg T; Tournier I
    Hum Mol Genet; 2017 Jul; 26(14):2591-2602. PubMed ID: 28369373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased oxidative damage in carriers of the germline TP53 p.R337H mutation.
    Macedo GS; Lisbôa da Motta L; Giacomazzi J; Netto CB; Manfredini V; Vanzin CS; Vargas CR; Hainaut P; Klamt F; Ashton-Prolla P
    PLoS One; 2012; 7(10):e47010. PubMed ID: 23056559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.